| Rite Aid Pharmacy #11054 | |
| 361 S Cedar Crest Blvd, Allentown, Pennsylvania 18103 | |
| (610) 821-7999 |
| Name | Rite Aid Pharmacy #11054 |
|---|---|
| Organization Name | Thrift Drug Inc |
| Location | 361 S Cedar Crest Blvd, Allentown, Pennsylvania 18103 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (610) 821-7999 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
GTC Biotherapeutics, Inc.'s ("GTC", NASDAQ: GTCB) received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market (the "Staff Determination") on September 17, 2009, indicating that unless GTC requests a hearing before the NASDAQ Listing Qualifications Panel (the "Panel"), the Company's securities would be subject to delisting from The NASDAQ Capital Market due to non-compliance with the $35 million market value of listed securities requirement as set forth in Listing Rule 5550(b)(2).
The University of Texas MD Anderson Cancer Center has been awarded $12.75 million from the Cancer Prevention and Research Institute of Texas to support basic, clinical, translational and prevention research efforts, including $3 million for a new project to build clinical trial network infrastructure across Texas.
When people with severe sepsis, an extreme overreaction by the body to a serious infection, come to the emergency room, they require timely, expert care to prevent organ failure and even death.
Additional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 6 days ago
| NPI Number | 1649371444 |
| Organization Name | THRIFT DRUG INC |
| Doing Business As | RITE AID PHARMACY 11054 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 361 South Cedar Crest Boulevard, Allentown, PA 18103 |
| Phone Number | 610-821-7999 |
News Archive
GTC Biotherapeutics, Inc.'s ("GTC", NASDAQ: GTCB) received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market (the "Staff Determination") on September 17, 2009, indicating that unless GTC requests a hearing before the NASDAQ Listing Qualifications Panel (the "Panel"), the Company's securities would be subject to delisting from The NASDAQ Capital Market due to non-compliance with the $35 million market value of listed securities requirement as set forth in Listing Rule 5550(b)(2).
The University of Texas MD Anderson Cancer Center has been awarded $12.75 million from the Cancer Prevention and Research Institute of Texas to support basic, clinical, translational and prevention research efforts, including $3 million for a new project to build clinical trial network infrastructure across Texas.
When people with severe sepsis, an extreme overreaction by the body to a serious infection, come to the emergency room, they require timely, expert care to prevent organ failure and even death.
Additional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 6 days ago
News Archive
GTC Biotherapeutics, Inc.'s ("GTC", NASDAQ: GTCB) received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market (the "Staff Determination") on September 17, 2009, indicating that unless GTC requests a hearing before the NASDAQ Listing Qualifications Panel (the "Panel"), the Company's securities would be subject to delisting from The NASDAQ Capital Market due to non-compliance with the $35 million market value of listed securities requirement as set forth in Listing Rule 5550(b)(2).
The University of Texas MD Anderson Cancer Center has been awarded $12.75 million from the Cancer Prevention and Research Institute of Texas to support basic, clinical, translational and prevention research efforts, including $3 million for a new project to build clinical trial network infrastructure across Texas.
When people with severe sepsis, an extreme overreaction by the body to a serious infection, come to the emergency room, they require timely, expert care to prevent organ failure and even death.
Additional research is needed before laser therapy can be recommended as a treatment for acne, according to a study in the June 16 issue of the Journal of the American Medical Association (JAMA).
NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 6 days ago
Amercian Home Medical Equipment And Type: Durable Medical Equipment & Medical Supplies Supplier Location: 754 Roble Rd, Allentown, Pennsylvania 18109 Phone: (610) 443-3014 | |
Bausch And Jones Eye Associates Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1616 W Allen St, Allentown, Pennsylvania 18102 Phone: (610) 432-0201 | |
Baird Medical Type: DME Supplier - Oxygen Equipment & Supplies Location: 4502 Hamilton Blvd, Allentown, Pennsylvania 18103 Phone: (610) 395-7028 | |
Boas Surgical, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3050 Hamilton Blvd, Allentown, Pennsylvania 18103 Phone: (610) 432-6736 | |
Cedar Crest Vision Care Type: Pharmacy Location: 1251 S Cedar Crest Blvd, Allentown, Pennsylvania 18103 Phone: (610) 435-5561 |